bpc 157 infusion BPC-157 Peptide Therapy BPC-157 Peptide Therapy | Doctors

BPC-157s human trials were early-phase IBD

Here is what the current body of research (which is predominantly animal studies) suggests BPC-157 does: Promotes angiogenesis: It appears to upregulate VEGF (vascular endothelial growth factor) signaling, stimulating the growth of new blood vessels into damaged tissue

When attending an appointment, it may be helpful to: Bring a list of your current medications , including any supplements or over-the-counter products Discuss your weight history and previous treatment attempts , including any prior use of GLP-1 agonists Ask specifically about clinical trial eligibility , as some NHS trusts and academic centres are actively recruiting for obesity-related studies Raise any concerns about online sources offering unlicensed peptides, so your clinician can provide appropriate safety guidance Your GP can refer you to NHS Tier 3 specialist weight management services if you meet the relevant criteria

Its also recommended to be cautious in people on certain medications like levodopa (without carbidopa), as mentioned, or those with specific medical conditions, but these are matters of caution rather than strict contraindications

Eur Rev Med Pharmacol Sci